Citation: Lp. Frohman et al., Neuro-ophthalmic manifestations of sarcoidosis: Clinical spectrum, evaluation, and management, J NEURO-OPH, 21(2), 2001, pp. 132-137
Authors:
Brown, KM
Middaugh, SJ
Haythornthwaite, JA
Bielory, L
Citation: Km. Brown et al., The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks: The Raynaud's Treatment Study, J BEHAV MED, 24(2), 2001, pp. 137-153
Authors:
Bielory, L
Piccone, F
Rabinowitz, P
Rossoff, L
Winder, J
Incaudo, G
Wu, J
Newman, K
Citation: L. Bielory et al., Multicentre, randomised, parallel-group study of the efficacy and tolerability of flunisolide administered once daily via AeroChamber (R) in the treatment of mild to moderate asthma, CLIN DRUG I, 19(2), 2000, pp. 93-101
Authors:
Wigley, FM
Wise, R
Haythornthwaite, J
Rand, C
Smith, EA
Maricq, HR
Middaugh, S
Silver, RM
Valter, I
Allenback, G
Arnold, J
Steedman, S
Risinger, A
King, A
Bielory, L
Attanasio, V
Tarantola, J
Centeno, L
Jacob, RG
Medsger, T
Jennings, R
Scheier, M
Vaughan, C
Wasko, MC
Steen, VD
Dunbar-Jacob, J
Tamres, L
Freedman, RR
Mayes, MD
Brejnak, C
Tindall, C
Bielory, L
Thompson, B
Frederick, M
Canner, M
Canner, J
Canner, P
Shaffer, TR
Hill, DR
Kaufmann, PG
Czajkowski, S
Geller, N
Hunsberger, S
Jennings, C
Stevens, WM
Hess, EV
Corson, JA
Jobe, JB
Smith, H
Tilley, B
Citation: Fm. Wigley et al., Comparison of sustained-release nifedipine and temperature biofeedback fortreatment of primary Raynaud phenomenon - Results from a randomized clinical trial with 1-year follow-up, ARCH IN MED, 160(8), 2000, pp. 1101-1108
Citation: M. Dinowitz et al., Ocular allergic diseases: Differential diagnosis, examination techniques, and testing, CL ALLER IM, 15, 2000, pp. 127-150
Citation: L. Bielory et J. Oppenheimer, Reversible obstructive airway disease, REHABILITATION OF THE PATIENT WITH RESPIRATORY DISEASE, 1999, pp. 287-294
Authors:
Nathan, RA
Bernstein, JA
Bielory, L
Bonuccelli, CM
Calhoun, WJ
Galant, SP
Hanby, LA
Kemp, JP
Kylstra, JW
Nayak, AS
O'Connor, JP
Schwartz, HJ
Southern, DL
Spector, SL
Williams, PV
Citation: Ra. Nathan et al., Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction, J ALLERG CL, 102(6), 1998, pp. 935-942